Skip to content
MomMetabolicEVIDENCE-FIRST METABOLIC HEALTH
Menu
Grade C

Lyfe Rx review

Written by Elena Voss, Metabolic Health Editor

Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.

The FDA issued Lyfe Rx a September 9, 2025 warning letter over false or misleading compounded semaglutide and tirzepatide claims. Monthly autoship costs $225.50 for semaglutide or $327.18 for tirzepatide; one-time fills cost $275 or $399, with medication, supplies, provider support and shipping included.

$225.5/mo
Flat price · every dose
Consult Medication Shipping
See plans at Lyfe Rx
  • Confirm HSA / FSA coverage
  • Public information reviewed
  • Confirm your total cost
Compare alternatives ↓

Lyfe Rx at a glance

Semaglutide
$225.50/mo monthly autoship; $275 one-time fill
Tirzepatide
$327.18/mo monthly autoship; $399 one-time fill
Coverage
All states except Alabama
Brand-name
Compounded only

How we scored Lyfe Rx

Every factor comes from Lyfe Rx's own published pricing, disclosures and oversight, and the six combine into the 28/100 Metabolic-Fit Score on our weighted six-factor framework. Commissions don't change a provider's score.

Postpartum & breastfeeding guidance10/100 · Weak

No postpartum or breastfeeding framing — a generic weight program.

PCOS & hormonal fit22/100 · Weak

Thin on the hormonal picture that drives many mothers' weight.

Clinical oversight & labs20/100 · Weak

Oversight and lab support fall short of the best on our list — the review below says exactly where.

True monthly cost58/100 · Weak

Cost is unpredictable or sits at the premium end.

Ongoing support35/100 · Weak

Support is thin once the prescription ships.

Cancellation fairness40/100 · Weak

Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.

How we checked this review

Semaglutide: $275 per fill; $225.50 monthly autoship; tirzepatide: $399 per fill; $327.18 monthly autoship. One-time fills cost $275 and $399; optional autoship reduces the price and three-month autoship requires $618.75 or $897.75.

Before you sign up

What Lyfe Rx's public site and signup page show before you hand over any details.

Worth knowing

  • Regular pricing is stated directly on the page, before any account creation
  • The site itself makes no mention of its own FDA warning letter — that fact came from FDA.gov, not the provider's own copy
  • The FDA issued Lyfe Rx a warning letter dated 09/09/2025, addressed to Lyfe Rx's website by name, for misbranding under FDCA sections 502(a) and 502(bb) — the FDA's letter says the site's claims about compounded semaglutide and tirzepatide were false or misleading
  • The site displays a LegitScript Certified badge and states it ships everywhere except Alabama
  • We did not create an account or complete checkout — pricing facts come from the public site; the regulatory finding comes from FDA.gov

Pricing

MedicationPricePlan
Compounded semaglutide$225.5Compounded semaglutide$275 per fill; $225.50 monthly autoship. One-time fills cost $275 and $399; optional autoship reduces the price and three-month autoship requires $618.75 or $897.75.
Compounded tirzepatide$327.18Compounded tirzepatide$399 per fill; $327.18 monthly autoship. One-time fills cost $275 and $399; optional autoship reduces the price and three-month autoship requires $618.75 or $897.75.

Swipe the table to see plan details →

Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what Lyfe Rx's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.

What we like

  • Semaglutide: $275 per fill; $225.50 monthly autoship; tirzepatide: $399 per fill; $327.18 monthly autoship.
  • Broad state coverage — ships to all states except Alabama
  • Both molecules available on one site
  • LegitScript Certified badge displayed

The caveats

  • One-time fills cost $275 and $399; optional autoship reduces the price and three-month autoship requires $618.75 or $897.75.
  • The FDA issued Lyfe Rx an FDA warning letter dated 09/09/2025 for making false or misleading claims about its compounded semaglutide and tirzepatide products (misbranding under FDCA 502(a)/502(bb)) — confirmed on FDA.gov
  • The site makes no mention of the warning letter anywhere in its own copy
  • Not available in Alabama
  • No mention anywhere of pregnancy, breastfeeding, postpartum recovery, or PCOS

One-time purchases and autoship have different prices

Lyfe Rx lists a semaglutide fill at $275, or $225.50 with monthly autoship. Tirzepatide is $399 per fill, or $327.18 with monthly autoship. These are distinct purchase choices. A reader who wants a single order should not budget using the lower recurring amount without choosing and understanding the autoship arrangement.

Three-month autoship options require $618.75 for semaglutide or $897.75 for tirzepatide. Those totals should be compared with the amount due now, not treated as independent monthly charges. Ask how much medication each order supplies, how renewal works and what happens if the prescribed dose or formulation changes before the paid period is complete.

The FDA warning letter is a specific historical fact

The FDA issued a warning letter to Lyfe Rx dated September 9, 2025, concerning claims about compounded semaglutide and tirzepatide on Lyfe Rx's website. The letter addressed false or misleading claims and misbranding under the cited statutory provisions. This is a regulator’s action tied to this seller, rather than a letter inferred from a similar company name.

That historical finding should remain part of the decision even when prices change. It does not establish that every later prescription is unsafe or settle whether every cited statement remains online today. A patient should read the letter’s actual scope, distinguish its date from the current offer and ask how the seller now describes the compounded products it supplies.

A certification badge does not erase that distinction

Lyfe displays a LegitScript certification badge. That is a separate claim to verify against its linked certification record; it does not turn a compounded formulation into an FDA-approved finished product or cancel the historical warning letter. Both pieces of information can be relevant without treating one as proof that the other no longer matters.

Ask the prescriber which product is being recommended, which licensed pharmacy prepares it and what evidence supports any claims attached to that exact formulation. The product’s ingredients, intended quantity and instructions should be clear before purchasing, particularly when comparing compounded care with a named approved brand rather than another compounded storefront.

Recurring savings need clear stopping rules

The lower autoship amount is useful only if the recurring arrangement suits the patient. Establish the next order date, the method and deadline for stopping shipment, and whether pharmacy preparation changes cancellation eligibility. A discount for automatic renewal does not establish a general refund right for medication that has already been dispensed.

The longer autoship option requires additional care because the initial payment covers more than a single recurring purchase. Ask how a clinician-directed change is handled and whether any unused portion can be credited or refunded under the actual terms. Do not infer those rights from the word subscription or from the price difference between one-time and recurring orders.

Check both coverage and the clinical relationship

Lyfe’s public coverage information excludes Alabama. Its public information does not establish a dedicated pregnancy, breastfeeding, postpartum or PCOS program. Those needs should be discussed with the responsible clinician before deciding that the service fits, particularly before committing to several months of medication purchases.

Lyfe Rx’s decision points are the choice between one-time and automatic orders, the actual payment attached to each and the historical regulatory finding. Someone considering it should seek a clear product explanation and a dependable route to clinical follow-up. A lower autoship price is a financial feature, while the warning letter, pharmacy identity and quality of the treating relationship require their own assessment.

The bottom line for mothers

Best for: Readers who can compare the full payment commitment and confirm the renewal amount before choosing a plan.

Alternatives to Lyfe Rx

These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.

  • CoreAge RxFeatured partner

    CoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.

    Visit CoreAge Rx
  • $165/mo semaglutide and $214/mo tirzepatide month to month, dropping to $97 and $177 on a 12-month plan — with a genuinely itemized exclusion list that explicitly screens out pregnancy, planned pregnancy, and breastfeeding rather than staying silent on it.

    Visit HealthRX
  • A complete plan table and real nationwide coverage, undercut by a homepage that strikes the same product through from two different “regular” prices.

    Visit bmiMD

Providers like Lyfe Rx

Keep comparing Lyfe Rx

Lyfe Rx, answered

Does Lyfe Rx have an FDA warning letter?
Yes — the FDA issued one dated 09/09/2025, addressed to Lyfe Rx's website by name, for misbranding claims about its compounded semaglutide and tirzepatide products. We confirmed this directly on FDA.gov; the site itself does not mention it.
Is Lyfe Rx still operating despite the warning letter?
Yes, as of our August 4, 2026 check its site is live and actively selling compounded semaglutide and tirzepatide at the prices above. A warning letter is not a shutdown order, but it's a real regulatory finding worth weighing before you sign up.

Pricing, states and verification reflect Lyfe Rx's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.

← Back to all providers